US 12053526
Methods for treatment using anti-alpha4beta7 antibody
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 12053526 (Methods for treatment using anti-alpha4beta7 antibody) held by Takeda Pharmaceutical Company Limited expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 34
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K39/395